BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 30290303)

  • 1. Microstructural brain changes track cognitive decline in mild cognitive impairment.
    Reas ET; Hagler DJ; White NS; Kuperman JM; Bartsch H; Wierenga CE; Galasko D; Brewer JB; Dale AM; McEvoy LK
    Neuroimage Clin; 2018; 20():883-891. PubMed ID: 30290303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease.
    Reas ET; Hagler DJ; White NS; Kuperman JM; Bartsch H; Cross K; Loi RQ; Balachandra AR; Meloy MJ; Wierenga CE; Galasko D; Brewer JB; Dale AM; McEvoy LK
    Alzheimers Res Ther; 2017 Aug; 9(1):55. PubMed ID: 28764771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia.
    Reas ET; Hagler DJ; Kuperman JM; Wierenga CE; Galasko D; White NS; Dale AM; Banks SJ; McEvoy LK; Brewer JB
    J Alzheimers Dis; 2020; 73(1):347-357. PubMed ID: 31796676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
    Reas ET; Triebswetter C; Banks SJ; McEvoy LK
    Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
    Kumar A; Singh S; Verma A; Mishra VN
    Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter integrity disruption in the pre-dementia stages of Alzheimer's disease: from subjective memory impairment to amnestic mild cognitive impairment.
    Shao W; Li X; Zhang J; Yang C; Tao W; Zhang S; Zhang Z; Peng D
    Eur J Neurol; 2019 May; 26(5):800-807. PubMed ID: 30584694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate statistical analysis of diffusion imaging parameters using partial least squares: Application to white matter variations in Alzheimer's disease.
    Konukoglu E; Coutu JP; Salat DH; Fischl B;
    Neuroimage; 2016 Jul; 134():573-586. PubMed ID: 27103138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orientational changes of white matter fibers in Alzheimer's disease and amnestic mild cognitive impairment.
    Zhao H; Cheng J; Liu T; Jiang J; Koch F; Sachdev PS; Basser PJ; Wen W;
    Hum Brain Mapp; 2021 Nov; 42(16):5397-5408. PubMed ID: 34412149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of diffusion tensor imaging for evaluating changes in the microstructural integrity of white matter over 3 years in patients with amnesic-type mild cognitive impairment converting to Alzheimer's disease.
    Fu JL; Liu Y; Li YM; Chang C; Li WB
    J Neuroimaging; 2014; 24(4):343-8. PubMed ID: 24251793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
    Brueggen K; Dyrba M; Cardenas-Blanco A; Schneider A; Fliessbach K; Buerger K; Janowitz D; Peters O; Menne F; Priller J; Spruth E; Wiltfang J; Vukovich R; Laske C; Buchmann M; Wagner M; Röske S; Spottke A; Rudolph J; Metzger CD; Kilimann I; Dobisch L; Düzel E; Jessen F; Teipel SJ;
    J Neurol; 2019 Oct; 266(10):2465-2474. PubMed ID: 31227891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
    Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective changes in white matter integrity in MCI and older adults with cognitive complaints.
    Wang Y; West JD; Flashman LA; Wishart HA; Santulli RB; Rabin LA; Pare N; Arfanakis K; Saykin AJ
    Biochim Biophys Acta; 2012 Mar; 1822(3):423-30. PubMed ID: 21867750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential microstructural and morphological abnormalities in mild cognitive impairment and Alzheimer's disease: Evidence from cortical and deep gray matter.
    Gong NJ; Chan CC; Leung LM; Wong CS; Dibb R; Liu C
    Hum Brain Mapp; 2017 May; 38(5):2495-2508. PubMed ID: 28176436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shades of white: diffusion properties of T1- and FLAIR-defined white matter signal abnormalities differ in stages from cognitively normal to dementia.
    Riphagen JM; Gronenschild EHBM; Salat DH; Freeze WM; Ivanov D; Clerx L; Verhey FRJ; Aalten P; Jacobs HIL
    Neurobiol Aging; 2018 Aug; 68():48-58. PubMed ID: 29704648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal and entorhinal structures in subjective memory impairment: a combined MRI volumetric and DTI study.
    Ryu SY; Lim EY; Na S; Shim YS; Cho JH; Yoon B; Hong YJ; Yang DW
    Int Psychogeriatr; 2017 May; 29(5):785-792. PubMed ID: 28067183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.